Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value:
$822.62M
Total Bought:
$378.62M
Total Sold:
$184.01M
Net Transaction:
+$194.62M
Notable People:
Ting (Nmn) Jia, Octagon Capital Advisors, Llc
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Apellis Pharmaceuticals Inc
COM
2,806,9802,806,9800$168.03M$164.99M20.06%-$3.03M
Alpine Immune Sciences Inc1,241,3001,241,3000$23.66M$49.21M5.98%+$25.55M
Dianthus Therapeutics, Inc.(DNTH)554,0001,380,667+826,667$5.76M$41.42M5.04%+$35.66M
Verona Pharma PlcADS2,369,0002,369,0000$47.10M$38.12M4.63%-$8.98M
Dyne Therapeutics, Inc.(DYN)792,9451,242,945+450,000$10.55M$35.29M4.29%+$24.74M
ArriVent BioPharma, Inc.(AVBP)01,943,836+1,943,836$0$34.72M4.22%+$34.72M
Insmed Incorporated(INSM)1,284,0001,140,000-144,000$39.79M$30.93M3.76%-$8.86M
Centessa Pharmaceuticals PlcADS2,060,1002,060,1000$16.40M$23.28M2.83%+$6.88M
EyePoint, Inc.(EYPT)01,093,503+1,093,503$0$22.60M2.75%+$22.60M
Ocular Therapeutix, Inc.(OCUL)02,425,000+2,425,000$0$22.07M2.68%+$22.07M
Structure Therapeutics IncADS414,000506,604+92,604$16.87M$21.71M2.64%+$4.84M
BridgeBio Pharma, Inc.(BBIO)706,800690,000-16,800$28.53M$21.33M2.59%-$7.20M
Mind Medicine Mindmed Inc02,153,000+2,153,000$0$20.24M2.46%+$20.24M
Perspective Therapeutics, Inc.(CATX)014,718,422+14,718,422$0$17.51M2.13%+$17.51M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0405,000+405,000$0$15.89M1.93%+$15.89M
Praxis Precision Medicines, Inc.(PRAX)0260,000+260,000$0$15.87M1.93%+$15.87M
Tenaya Therapeutics, Inc.(TNYA)02,854,000+2,854,000$0$14.93M1.81%+$14.93M
Jasper Therapeutics, Inc.(JSPR)0500,811+500,811$0$14.70M1.79%+$14.70M
Annexon, Inc.(ANNX)2,050,0002,050,0000$9.31M$14.70M1.79%+$5.39M
Cytokinetics, Incorporated(CYTK)116,000194,000+78,000$9.68M$13.60M1.65%+$3.92M
Aerovate Therapeutics Inc403,685403,6850$9.14M$11.94M1.45%+$2.80M
Viridian Therapeutics, Inc.(VRDN)620,000620,0000$13.50M$10.86M1.32%-$2.65M
Gossamer Bio, Inc.(GOSS)9,187,8839,187,8830$8.38M$10.84M1.32%+$2.46M
Newamsterdam Pharma Company
ORDINARY SHARES
0408,000+408,000$0$9.65M1.17%+$9.65M
Glycomimetics Inc3,000,0003,000,0000$7.08M$9.00M1.09%+$1.92M
Immunovant, Inc.(IMVT)273,289273,2890$11.51M$8.83M1.07%-$2.68M
Taysha Gene Therapies, Inc.(TSHA)03,030,000+3,030,000$0$8.70M1.06%+$8.70M
Akero Therapeutics Inc0340,000+340,000$0$8.59M1.04%+$8.59M
Ventyx Biosciences Inc01,501,114+1,501,114$0$8.26M1.00%+$8.26M
Cybin D/B/A Helus Pharma(HELP)018,604,650+18,604,650$0$7.69M0.94%+$7.69M
Arrowhead Pharmaceuticals, Inc.(ARWR)0250,000+250,000$0$7.15M0.87%+$7.15M
Mineralys Therapeutics, Inc.(MLYS)0550,000+550,000$0$7.10M0.86%+$7.10M
Silence Therapeutics plcADS(SLN)0315,000+315,000$0$6.80M0.83%+$6.80M
PepGen Inc.(PEPG)0376,117+376,117$0$5.53M0.67%+$5.53M
Vincerx Pharma Inc01,000,000+1,000,000$0$5.06M0.62%+$5.06M
Nuvation Bio Inc.CL A(NUVB)1,000,0001,374,870+374,870$1.51M$5.00M0.61%+$3.49M
Phathom Pharmaceuticals, Inc.(PHAT)50,000455,000+405,000$456.5K$4.83M0.59%+$4.38M
Mersana Therapeutics Inc01,000,000+1,000,000$0$4.48M0.54%+$4.48M
Terns Pharmaceuticals Inc0625,000+625,000$0$4.10M0.50%+$4.10M
Fate Therapeutics, Inc.(FATE)0520,800+520,800$0$3.82M0.46%+$3.82M
Reneo Pharmaceuticals Inc2,250,0002,250,0000$3.60M$3.73M0.45%+$135.0K
Anaptysbio Inc120,000165,000+45,000$2.57M$3.72M0.45%+$1.15M
Sana Biotechnology, Inc.(SANA)0360,800+360,800$0$3.61M0.44%+$3.61M
An2 Therapeutics Inc664,5751,103,000+438,425$13.62M$3.58M0.44%-$10.03M
Allogene Therapeutics Inc0720,000+720,000$0$3.22M0.39%+$3.22M
Allovir Inc04,200,000+4,200,000$0$3.17M0.39%+$3.17M
Veru Inc.(VERU)3,800,0003,800,0000$2.74M$2.66M0.32%-$75.6K
Rapt Therapeutics Inc292,000292,0000$7.26M$2.62M0.32%-$4.63M
Nkarta, Inc.(NKTX)0240,000+240,000$0$2.59M0.32%+$2.59M
Helix Acquisition Corp IiCL A0250,000+250,000$0$2.59M0.31%+$2.59M
Poseida Therapeutics Inc0736,000+736,000$0$2.35M0.29%+$2.35M
Century Therapeutics, Inc.(IPSC)0540,000+540,000$0$2.26M0.27%+$2.26M
Adicet Bio Inc0767,799+767,799$0$1.80M0.22%+$1.80M
Atyr Pharma Inc0700,000+700,000$0$1.36M0.17%+$1.36M
Autolus Therapeutics plcADS(AUTL)0176,000+176,000$0$1.12M0.14%+$1.12M
Cabaletta Bio, Inc.(CABA)052,000+52,000$0$887.1K0.11%+$887.1K
Aclaris Therapeutics, Inc.(ACRS)100,0000-100,000$105.0K$0—-$105.0K
Arcus Biosciences, Inc.(RCUS)1,868,0000-1,868,000$35.68M$0—-$35.68M
Celldex Therapeutics, Inc.(CLDX)707,5260-707,526$28.06M$0—-$28.06M
Cymabay Therapeutics Inc2,673,7500-2,673,750$63.15M$0—-$63.15M
Gracell Biotechnologies IncADS596,6110-596,611$5.99M$0—-$5.99M
Inozyme Pharma Inc400,0000-400,000$1.70M$0—-$1.70M
Jasper Therapeutics, Inc.(JSPR)4,468,1140-4,468,114$3.53M$0—-$3.53M
Mirum Pharmaceuticals, Inc.(MIRM)25,0000-25,000$738.0K$0—-$738.0K
Roivant Sciences Ltd.SHS(ROIV)2,494,0000-2,494,000$28.01M$0—-$28.01M
Xilio Therapeutics, Inc.(XLO)1,785,0000-1,785,000$981.8K$0—-$981.8K
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q1 2024 | TickerTrail